Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2010-02-05
2011-12-20
Ouspenski, Ilia (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
Reexamination Certificate
active
08080636
ABSTRACT:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.
REFERENCES:
patent: 6630575 (2003-10-01), Coyle et al.
patent: 6635750 (2003-10-01), Coyle et al.
patent: 7030219 (2006-04-01), Pardoll et al.
patent: 7368531 (2008-05-01), Rosen et al.
patent: 7411051 (2008-08-01), Rosen et al.
patent: 7414122 (2008-08-01), Fox et al.
patent: 7432059 (2008-10-01), Freeman et al.
patent: 7432062 (2008-10-01), Coyle et al.
patent: 7560540 (2009-07-01), Pardoll et al.
patent: 2002/0091246 (2002-07-01), Pardoll et al.
patent: 2002/0106730 (2002-08-01), Coyle et al.
patent: 2002/0107363 (2002-08-01), Fox et al.
patent: 2002/0110836 (2002-08-01), Freeman et al.
patent: 2002/0164600 (2002-11-01), Freeman et al.
patent: 2004/0137577 (2004-07-01), Coyle et al.
patent: 2004/0162236 (2004-08-01), Alsobrook et al.
patent: 2005/0228170 (2005-10-01), Fox et al.
patent: 2006/0292593 (2006-12-01), Pardoll et al.
patent: 2008/0118511 (2008-05-01), Freeman et al.
patent: 2008/0226662 (2008-09-01), Pardoll et al.
patent: 2008/0241175 (2008-10-01), Pardon et al.
patent: 2009/0004237 (2009-01-01), Fox et al.
patent: 2009/0269783 (2009-10-01), Coyle et al.
patent: 1074617 (2000-07-01), None
patent: 1067182 (2001-01-01), None
patent: 1074617 (2001-02-01), None
patent: WO9819706 (1998-05-01), None
patent: WO98/58965 (1998-12-01), None
patent: WO9946281 (1999-03-01), None
patent: WO 99/46281 (1999-09-01), None
patent: WO9947558 (1999-09-01), None
patent: WO 00/55375 (2000-09-01), None
patent: WO0053756 (2000-09-01), None
patent: WO 00/61612 (2000-10-01), None
patent: WO 00/68266 (2000-11-01), None
patent: WO0068266 (2000-11-01), None
patent: WO 01/14557 (2001-03-01), None
patent: WO 01/18021 (2001-03-01), None
patent: WO 01/18022 (2001-03-01), None
patent: WO 01/18204 (2001-03-01), None
patent: WO0114556 (2001-03-01), None
patent: WO0114566 (2001-03-01), None
patent: WO0114577 (2001-03-01), None
patent: WO0121631 (2001-03-01), None
patent: WO0134629 (2001-05-01), None
patent: WO0134768 (2001-05-01), None
patent: WO0139722 (2001-06-01), None
patent: WO 01/53312 (2001-07-01), None
patent: EP1130094 (2001-09-01), None
patent: WO0168848 (2001-09-01), None
patent: WO 01/77137 (2001-10-01), None
patent: WO 01/83750 (2001-11-01), None
patent: WO0183750 (2001-11-01), None
patent: WO 02/02587 (2002-01-01), None
patent: WO0200692 (2002-01-01), None
patent: WO0200730 (2002-01-01), None
patent: WO0208279 (2002-01-01), None
patent: WO0210187 (2002-02-01), None
patent: WO 02/24891 (2002-03-01), None
patent: WO0222683 (2002-03-01), None
patent: WO02097046 (2002-12-01), None
patent: WO03/014293 (2003-02-01), None
patent: WO03085124 (2003-10-01), None
patent: WO2004093894 (2004-11-01), None
Gerstmayer, et al., “Costimulation of T-cell proliferation by a chimeric B7-antibody fusion protein”, Cancer Immunol. Immunother., vol. 45, pp. 156-158 (1997).
Henry, et al., “Structure and evolution of the extended B7 family”, Immunol. Today, vol. 20, No. 6, pp. 285-288 (1999).
Stammers, et al., “BTL-II: a polymorphic locus with homology to the butyrophilin gene family, located at the border of the major histocompatibility complex class II and class III regions in human and mouse”, Immunogenetics, vol. 51, pp. 373-382 (2000).
NCBI Entrez Accession No. AF329193 (gi:13569409), Tseng, et al., Apr. 10, 2001.
NCBI Entrez Accession No. AF344424 (gi:13183882), Latchman, et al., Apr. 8, 2002.
NCBI Entrez Accession No. AL162253 (gi:13677203), Clark, G., May 6, 2008.
NCBI Entrez Accession No. Q9WUL5 (gi:68606058), Tseng, et al., Nov. 25, 2008.
Amendment and Response to Non-Final Office Action, In re: Freeman, et al., U.S. Appl. No. 11/765,838, filed Jun. 20, 2007, submitted Jan. 12, 2009 attaching Declaration Under 37 C.F.R. §1.131.
Supplemental Response to Non-Final Office Action, In re: Freeman, et al., U.S. Appl. No. 11/765,838, filed Jun. 20, 2007, submitted Feb. 19, 2009 attaching Declaration Under 37 C.F.R. §1.131.
NCBI Entrez Accession No. AAK15370 (gi:13183883), Latchman, et al., Apr. 8, 2002.
NCBI Entrez Accession No. AAK31105 (gi:13569410), Tseng, et al., Apr. 10, 2001.
NCBI Entrez Accession No. AAK15438(gi:13194193), Chapoval, et al., Mar. 3, 2001.
Ellison, et al., “The nucleotide sequence of a human immunoglobulin COI gene”, Nucleic Acids Res., vol. 10(13), pp. 4071-4079 (1982).
NCBI Entrez Accession No. gi:14741794 (Oct. 16, 2001).
NCBI Entrez Accession No. gi:22761770 (Sep. 3, 2002).
NCBI Entrez Accession No. gi:22760560 (Sep. 3, 2002).
NCBI Entrez Accession No. gi:16160937 (Oct. 16, 2001).
NCBI Entrez Accession No. gi:13376852 (Mar. 18, 2001).
NCBI Entrez Accession No. gi:13376850 (Mar. 18, 2001).
NCBI Entrez Accession No. gi:13640665 (Oct. 16, 2001).
Castriconi, et al., “Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis”, PNAS, vol. 101(34), pp. 12640-12645 (2004).
Collins, et al., “The B7 family of immune-regulatory ligands”, Genome Biol., vol. 6, pp. 223.1-223.7 (2005).
Dong, et al., “Immune Regulation by Novel Costimulatory Molecules”, Immunologic Res., vol. 28(1), pp. 39-48 (2003).
Ferlazzo, et al., “T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties”, Eur. J. Immunol., vol. 32, pp. 3092-3101 (2002).
Greenwald, et al., “The B7 Family Revisited”, Annu. Rev. Immunol., vol. 23, pp. 515-548 (2005).
Kim, et al., “Constitutive and Inducible Expression of B7 Family of Ligands by Human Airway Epithelial Cells”, Am. J. Respir. Cell Mol. Biol., vol. 33, pp. 280-289 (2005).
Lane, et al., “mRNA for Genes Associated with Antigen Presentation are Expressed by Human Middle Meatal Epithelial Cells in Culture”, The Laryngoscope, vol. 114, pp. 1827-1832 (2004).
Ling, et al., “Duplication of primate and rodent B7-H3 immunoglobulin V- and C- like domains: divergent history of functional redundancy and exon loss”, Genomics, vol. 82, pp. 365-377 (2003).
Loke, et al., Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells, Arthritis Res. Therapy, vol. 6(5), pp. 208-214 (2004).
Luo, et al., “B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+Cytolytic T Cells”, J. Immunol., vol. 173, pp. 5445-5450 (2004).
Petroff, et al., “The Immunomodulatory Proteins B7-DC, B7-H2, and B7-H3 Are Differentially Expressed across Gestation in the Human Placenta”, Amer. J. Pathology; vol. 167(2), pp. 465-473 (2005).
Prasad, et al., “Murine B7-H3 Is a Negative Regulator of T Cells”, J. Immunol., vol. 173, pp. 2500-2506 (2004).
Saatian, et al., “Expression of genes for B7-H3 and other T cell igands by nasal epithelial cells during differentiation and activation”, Am. J. Physiol. Lung Cell Mol. Physiol., vol. 287, pp. L127-L225 (2004).
Steinberger, et al., “Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains”, J. Immunol., vol. 172, pp. 2352-2359 (2004).
Suh, et al., The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses, Na
Chang Han
Mikesell Glen Eugene
Peach Robert James
Bristol--Myers Squibb Company
D'Amico Stephen C.
Ouspenski Ilia
LandOfFree
BSL3 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BSL3 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BSL3 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4307386